Volume 39 Issue 9
Sep.  2023
Turn off MathJax
Article Contents
Article Navigation >  Journal of Nanjing University of traditional Chinese Medicine  > 2023  >  39(9): 943-953
TONG Li-mei, JIANG Yin-xiu, GUO Sheng, ZHANG Fang, DUAN Jin-ao. Research Status and Development Strategy Analysis of Lycii fructus Medicinal and Edible Products[J]. Journal of Nanjing University of traditional Chinese Medicine, 2023, 39(9): 943-953. doi: 10.14148/j.issn.1672-0482.2023.0943
Citation: TONG Li-mei, JIANG Yin-xiu, GUO Sheng, ZHANG Fang, DUAN Jin-ao. Research Status and Development Strategy Analysis of Lycii fructus Medicinal and Edible Products[J]. Journal of Nanjing University of traditional Chinese Medicine, 2023, 39(9): 943-953. doi: 10.14148/j.issn.1672-0482.2023.0943
shu

Research Status and Development Strategy Analysis of Lycii fructus Medicinal and Edible Products

doi: 10.14148/j.issn.1672-0482.2023.0943

  • School of Pharmacy, Nanjing University of Chinese Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing 210023, China

  • Received Date: 2023-08-20
    Available Online: 2023-10-20
    Abstract
  • Lycii fructus is one of the officially approved medicinal materials with homologous medicinal and food sources. With the effects of nourishing the essence and eyesight, nourishing the liver and kidneys and diverse health functions, Lycii fructus has strong market demand and broad application prospects. This article summarized and systematically analyzed the current research status of medicinal and edible homologous products of Lycii fructus from the aspect of type quantity, efficacy attribution and functional analysis, commonly used compatible medicinal materials, processing methods, and dosage form of Chinese patent drug, as well as the health functions and common dosage forms of registered health foods. Furthermore, prominent issues in the research and development were sorted and explored, and reactive development strategies for subsequent research were proposed to provide references for new product development, value realization, quality and performance improvement.

     

    • FullText(HTML)
  • loading
    • References(31)
  • [1]
    张芳, 吴昌键, 张霞, 等. 基于Web of Science文献计量分析的宁夏枸杞研究现状和发展态势[J]. 中草药, 2022, 53(16): 5128-5141. doi: 10.7501/j.issn.0253-2670.2022.16.022

    ZHANG F, WU CJ, ZHANG X, et al. Research status and development trend of Lycium barbarum based on bibliometric analysis of Web of Science[J]. Chin Tradit Herb Drugs, 2022, 53(16): 5128-5141. doi: 10.7501/j.issn.0253-2670.2022.16.022
    [2]
    MA RH, ZHANG XX, NI ZJ, et al. Lycium barbarum (Goji) as functional food: A review of its nutrition, phytochemical structure, biological features, and food industry prospects[J]. Crit Rev Food Sci Nutr, 2022: 1-12.
    [3]
    APARECIDA PLASTINA CARDOSO M, WINDSON ISIDORO HAMINIUK C, PEDRO AC, et al. Biological effects of goji berry and the association with new industrial applications: A review[J]. Food Rev Int, 2023, 39(5): 2990-3007. doi: 10.1080/87559129.2021.2007261
    [4]
    ZHANG F, ZHANG X, LIANG XF, et al. Defensing against oxidative stress in Caenorhabditis elegans of a polysaccharide LFP-05S from lycii fructus[J]. Carbohydr Polym, 2022, 289: 119433. doi: 10.1016/j.carbpol.2022.119433
    [5]
    ZHANG F, ZHANG X, GUO S, et al. An acidic heteropolysaccharide from lycii fructus: Purification, characterization, neurotrophic and neuroprotective activities in vitro[J]. Carbohydr Polym, 2020, 249: 116894. doi: 10.1016/j.carbpol.2020.116894
    [6]
    国家药典委员会. 中华人民共和国药典: 一部[S]. 北京: 中国医药科技出版社, 2020.

    National Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China: Ⅰ[S]. Beijing: China medical science and technology press, 2020.
    [7]
    钟赣生, 杨柏灿. 中药学[M]. 北京: 中国中医药科技出版社, 2021.

    ZHONG GS, YANG BC. Traditional Chinese Medicine[M]. Beijing: China traditional Chinese medicine science and technology press, 2021.
    [8]
    黄璐琦, 何春年, 马培, 等. 我国药食两用物品产业发展战略思考[J]. 中国工程科学, 2022, 24(6): 81-87. https://www.cnki.com.cn/Article/CJFDTOTAL-GCKX202206009.htm

    HUANG LQ, HE CN, MA P, et al. Strategic thinking on the development of food-medicine industry[J]. Strateg Study CAE, 2022, 24(6): 81-87. https://www.cnki.com.cn/Article/CJFDTOTAL-GCKX202206009.htm
    [9]
    苏国辉. 面向人民健康重大需求, 建立脑疾病早期防治和后续康复体系[J]. 科技导报, 2022, 40(19): 1. https://www.cnki.com.cn/Article/CJFDTOTAL-KJDB202219013.htm

    SU GH. Focusing on the brain health strive to benefit People's lives and health[J]. Sci Technol Rev, 2022, 40(19): 1. https://www.cnki.com.cn/Article/CJFDTOTAL-KJDB202219013.htm
    [10]
    王智民, 刘晓谦, 高慧敏, 等. 发展大健康产业过程中的药食两用中药研发[J]. 中国药学杂志, 2017, 52(5): 333-336. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYX201705001.htm

    WANG ZM, LIU XQ, GAO HM, et al. Brief introduction of dietary Chinese medicines[J]. Chin Pharm J, 2017, 52(5): 333-336. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYX201705001.htm
    [11]
    吕朝耕, 康传志, 杨健, 等. 食药物质类中药材发展面临的问题与分化发展思路分析[J]. 中国中药杂志, 2022, 47(24): 6810-6816. doi: 10.19540/j.cnki.cjcmm.20220810.103

    LYU CG, KANG CZ, YANG J, et al. Problems and strategy of further development of Chinese medicinal materials with edible values[J]. China J Chin Mater Med, 2022, 47(24): 6810-6816. doi: 10.19540/j.cnki.cjcmm.20220810.103
    [12]
    胡婷婷, 陆艳, 粟月萍, 等. 基于专利视角的全国药食同源品种研发分析[J]. 中国科技信息, 2022(1): 13-16. https://www.cnki.com.cn/Article/CJFDTOTAL-XXJK202201005.htm

    HU TT, LU Y, SU YP, et al. Research and development of national medicinal and edible homologous varieties based on patent perspective[J]. China Sci Technol Inf, 2022(1): 13-16. https://www.cnki.com.cn/Article/CJFDTOTAL-XXJK202201005.htm
    [13]
    XIAO ZY, DENG Q, ZHOU WX, et al. Immune activities of polysaccharides isolated from Lycium barbarum L. What do we know so far?[J]. Pharmacol Ther, 2022, 229: 107921. doi: 10.1016/j.pharmthera.2021.107921
    [14]
    LIANG JJ, LI XH, LEI WZ, et al. Serum metabolomics combined with 16S rRNA sequencing to reveal the effects of Lycium barbarum polysaccharide on host metabolism and gut microbiota[J]. Food Res Int, 2023, 165: 112563. doi: 10.1016/j.foodres.2023.112563
    [15]
    ZHOU WT, YANG TT, XU WQ, et al. The polysaccharides from the fruits of Lycium barbarum L. confer anti-diabetic effect by regulating gut microbiota and intestinal barrier[J]. Carbohydr Polym, 2022, 291: 119626.
    [16]
    LAI WJ, WANG CY, LAI RF, et al. Lycium barbarum polysaccharide modulates gut microbiota to alleviate rheumatoid arthritis in a rat model[J]. NPJ Sci Food, 2022, 6(1): 34.
    [17]
    LIU JF, LI YC, PU QS, et al. A polysaccharide from Lycium barbarum L. : Structure and protective effects against oxidative stress and high-glucose-induced apoptosis in ARPE-19 cells[J]. Int J Biol Macromol, 2022, 201: 111-120.
    [18]
    SUN CX, CHEN X, YANG SP, et al. LBP1C-2 from Lycium barbarum alleviated age-related bone loss by targeting BMPRIA/BMPRⅡ/Noggin[J]. Carbohydr Polym, 2023, 310: 120725.
    [19]
    ZHENG HL, LIANG XF, ZHOU HL, et al. Integrated gut microbiota and fecal metabolome analyses of the effect of Lycium barbarum polysaccharide on D-galactose-induced premature ovarian insufficiency[J]. Food Funct, 2023, 14(15): 7209-7221.
    [20]
    段晨晨, 赵文晓, 吕琴, 等. 药食同源类中药多糖在功能性保健食品方面的药理作用研究进展[J]. 世界科学技术-中医药现代化, 2022, 24(10): 3844-3850. https://www.cnki.com.cn/Article/CJFDTOTAL-SJKX202210024.htm

    DUAN CC, ZHAO WX, LYU Q, et al. Research progress on pharmacological effects of medicinal and edible polysaccharides in functional health foods[J]. Mod Tradit Chin Med Mater Med World Sci Technol, 2022, 24(10): 3844-3850. https://www.cnki.com.cn/Article/CJFDTOTAL-SJKX202210024.htm
    [21]
    刘超群, 任越, 张燕玲. 药食同源食品质量控制的研究现状及策略[J]. 中国中药杂志, 2022, 47(14): 3963-3967. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY202214032.htm

    LIU CQ, REN Y, ZHANG YL. Research status and strategy of quality control of medicinal and edible food[J]. China J Chin Mater Med, 2022, 47(14): 3963-3967. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY202214032.htm
    [22]
    王宇, 任雪阳, 李留洋, 等. 基于数据挖掘和复杂网络的枸杞子提取物保健食品组方规律及质量控制分析[J]. 食品与发酵工业, 2023, 1-11.

    WANG Y, REN XY, LI LY, et al. Analysis on formula regularity and quality control of health food containing Lycium barbarum extract based on data mining and complex network[J]. Food and Fermentation Industries, 2023, 1-11.
    [23]
    钟叶, 裴志斐, 王博龙. 抗疲劳药食类产品基本分析及其中药使用规律研究[J]. 中成药, 2023, 45(7): 2447-2450. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYA202307060.htm

    ZHONG Y, PEI ZF, WANG BL. Basic analysis of anti-fatigue medicine and food products and study on the law of traditional Chinese medicine use[J]. Chin Tradit Pat Med, 2023, 45(7): 2447-2450. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYA202307060.htm
    [24]
    华玥, 刘建书, 袁立霞, 等. 基于中医辨证理论对中药保健食品功能的探讨[J]. 中华中医药杂志, 2022, 37(9): 5005-5008. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202209025.htm

    HUA Y, LIU JS, YUAN LX, et al. Discussion on health care functions of domestic health food formulated with traditional Chinese medicine based on Chinese medicine theory[J]. China J Tradit Chin Med Pharm, 2022, 37(9): 5005-5008. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202209025.htm
    [25]
    MIKKELSEN MB, OYVIND H, TOR M, et al. Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting[J]. Cost Eff Resour Alloc, 2023, 21(1): 52.
    [26]
    张芳, 郭盛, 钱大玮, 等. 枸杞多糖的提取纯化与分子结构研究进展及产业化开发现状与前景分析[J]. 中草药, 2017, 48(3): 424-432. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO201703002.htm

    ZHANG F, GUO S, QIAN DW, et al. Research progress on extraction, purification, and molecular structural elucidation of active polysaccharide from Lycii Fructus and analysis on its industrial development status and prospect[J]. Chin Tradit Herb Drugs, 2017, 48(3): 424-432. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO201703002.htm
    [27]
    HE ZD, MA TY, ZHANG WW, et al. Heat-induced gel formation by whey protein isolate-Lycium barbarum polysaccharides at varying pHs[J]. Food Hydrocoll, 2021, 115: 106607.
    [28]
    HU JX, LIU JF, HUANG XY, et al. Efficient extraction of polysaccharides from Lycium barbarum L. by aqueous two-phase system combined with tissue-smashing extraction[J]. Ind Crops Prod, 2022, 184: 115036.
    [29]
    CHEN DJ, GUO S, ZHOU JF, et al. Chemical constituents from Lycium barbarum (Solanaceae) and their chemophenetic significance[J]. Biochem Syst Ecol, 2021, 97: 104292.
    [30]
    CHEN H, ZHANG WJ, KONG JB, et al. Structurally diverse phenolic amides from the fruits of Lycium barbarum with potent α-glucosidase, dipeptidyl peptidase-4 inhibitory, and PPAR-γ agonistic activities[J]. J Agric Food Chem, 2023, 71(29): 11080-11093.
    [31]
    胡思, 王超, 孙贵香, 等. 大健康产业背景下药食同源资源开发的现状与对策研究[J]. 湖南中医药大学学报, 2021, 41(5): 815-820. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZX202105032.htm

    HU S, WANG C, SUN GX, et al. Research on the development status and countermeasures of medicine and food homologous resources under the background of big health industry[J]. J Hunan Univ Chin Med, 2021, 41(5): 815-820. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZX202105032.htm
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(7)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (372) PDF downloads(39) Cited by()
    Proportional views
    Related

    Copyright © Journal of Nanjing University of traditional Chinese Medicine

    Sponsored by：Nanjing University of traditional Chinese MedicineAddress：No.138 xianlin Avenue, Qixia District, Nanjing cityChina Pos：210023

    Tel：025-85811935Email：xb@njucm.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return